Currently Browsing: Resources

ACRO supports our member companies as they strongly recommend that their employees be fully vaccinated as quickly as possible

September 8, 2021

The Association of Clinical Research Organizations (ACRO) represents clinical research and technology companies that provide a variety of specialized tools and services…

Central Drugs Standard Control Organisation Guidance: Rapid Response Regulatory Framework for COVID-19 Vaccine development -reg.

June 9, 2020

Food and Drug Administration Guidance: COVID-19: Developing Drugs and Biological Products for Treatment or Prevention

June 2, 2020

Health Canada Guidance: Applications for drug clinical trials under the Interim Order

June 2, 2020

National Medical Product Administration Blogpost: Research well underway into COVID-19 vaccines and drugs, premier says

June 2, 2020

Food and Drug Administration Guidance: FDA Combatting COVID-19 with Medical Devices

May 27, 2020

Federal Institute for Drugs and Medical Devices Guidance: Supplementary Recommendations to EU Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic (Version 3.0)

May 27, 2020

European Medicines Agency Report: Treatments and vaccines for COVID-19

May 27, 2020

National Institute for Health Research Guidance: A framework for restarting NIHR research activities which have been paused due to COVID-19

May 21, 2020

European Medicines Agency Guidance: Guidance for medicine developers and companies on COVID-19

May 8, 2020

Food and Drug Administration Blogpost: Insight into FDA’s Revised Policy on Antibody Tests: Prioritizing Access and Accuracy

May 8, 2020

Food and Drug Administration Press Release: Coronavirus (COVID-19) Update: FDA Continues to Ensure Availability of Alcohol-Based Hand Sanitizer During the COVID-19 Pandemic, Addresses Safety Concerns

April 30, 2020

European Medicines Agency Press Release: International regulators pledge collective support to combat COVID-19 pandemic

April 30, 2020

Food and Drug Administration Blogpost: The Path Forward: Coronavirus Treatment Acceleration Program

April 30, 2020

European Commission Press Release: Coronavirus: Commission issues guidance to mitigate clinical trial disruption in the EU

April 28, 2020

National Medical Products Administration Press Release: China to speed up resuming normal medical services in low-risk regions

April 23, 2020

Food and Drug Administration Press Release: Coronavirus (COVID-19) Update: FDA Authorizes First Test for Patient At-Home Sample Collection

April 23, 2020

Medicines and Healthcare products Regulatory Agency Guidance: MHRA regulatory flexibilities resulting from coronavirus (COVID-19)

April 23, 2020

European Medicines Agency Press Release: Launch of enhanced monitoring system for availability of medicines used for treating COVID-19

April 23, 2020

European Commission Notice: Questions and Answers on Regulatory Expectations for Medicinal Products for Human Use during the COVID-19 Pandemic

April 23, 2020